Baxter Healthcare product recalled over sterility concerns
- Recall date
- July 6, 2017
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Baxter Healthcare Corporation recalls 0.9% Sodium Chloride Injection, USP, 100 mL VIAFLEX Container, Rx Only, Baxter Healthcare Corporation, Deerfield IL 600…
- Recall number
- D-0973-2017
- FDA classification
- Class II
- Brand / firm
- Baxter Healthcare Corporation
- Sold / distributed
- Nationwide, Puerto Rico and Saudi Arabia
Why it was recalled
Lack of Assurance of Sterility: Bags have the potential to leak.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
0.9% Sodium Chloride Injection, USP, 100 mL VIAFLEX Container, Rx Only, Baxter Healthcare Corporation, Deerfield IL 60015 USA, Product Code: 2B1309, NDC: 0338-0049-38
Get recall alerts
Free email alert whenever Baxter Healthcare Corporation has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Baxter Healthcare Corporation